Jon Slezak

Markey Cancer Center, University of Kentucky

Papers

Total Citations

H-Index

About

Jon Slezak is a clinical researcher whose work sits at the critical intersection of surgical innovation and oncologic outcomes in head and neck cancer, with a particular focus on oropharyngeal carcinoma. His research has helped define the modern treatment landscape for this disease, especially as the field grapples with the rising incidence of HPV-related oropharynx cancer. Slezak is best known for his comparative effectiveness studies, most notably his landmark 2019 paper comparing outcomes in surgically resectable oropharynx cancer treated with transoral robotic surgery (TORS) versus definitive chemoradiation—a work that has garnered 40 citations and directly informs shared decision-making between surgeons and radiation oncologists. His accompanying analysis of treatment trends, also published in 2019, documented how surgical technology has evolved to meet the epidemic of oropharyngeal carcinoma, providing essential context for understanding shifts in clinical practice. With these contributions, Slezak has established himself as a key voice in the ongoing debate over optimal treatment sequencing and de-escalation strategies, offering evidence that helps patients and clinicians navigate the trade-offs between functional preservation and oncologic control.